Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Dietary Supplement Industry Gains As Pallone, Harkin Named Chairs

This article was originally published in The Tan Sheet

Executive Summary

The dietary supplement industry gains an advocate in a key post on Capitol Hill with Rep. Frank Pallone's (D-N.J.) appointment as chairman of the House Energy and Commerce Committee's Health Subcommittee

You may also be interested in...

Adverse Event Bill Down To The Wire As Congress Wraps Up

Congress was poised late last week to pass a bill requiring mandatory adverse event reporting for dietary supplements and nonprescription drugs

Vitamin Distribution, Research Funding Planned Through HHS Appropriations

Rep. Frank Pallone (D-N.J.) wants to include language in the HHS appropriations bill that would provide $6 mil. to help expand a national program that donates multivitamins to children at risk for malnutrition and funds research on the benefits of dietary supplements in children.

Avoiding GMP “Showstoppers” Keeps Manufacturers Off FDA’s “Radar”

Compliance consultants warn that certain dietary supplement good manufacturing practices violations are inspection "showstoppers" and will draw agency enforcement


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts